Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global GABA (CAS 56-12-2) Market by Type (Chemical Synthesis, Biological Fermentation), By Application (Pharmaceuticals, Food & Beverage, Animal Feeds, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global GABA (CAS 56-12-2) Market by Type (Chemical Synthesis, Biological Fermentation), By Application (Pharmaceuticals, Food & Beverage, Animal Feeds, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 143734 3300 Chemical & Material 377 247 Pages 4.7 (47)
                                          

Global GABA (CAS 512) Market is expected to grow at a CAGR of XX% during the forecast period. The market is driven by the increasing demand for GABA in pharmaceuticals, food and beverage, and animal feeds. The growth of this market is also attributed to the increasing awareness about its health benefits among consumers. The global GABA (CAS 512) market has been segmented on the basis of type, application, and region. On the basis of type, it has been classified into chemical synthesis and biological fermentation. On the basis of application, it has been classified into pharmaceuticals, food & beverage industry and animal feed industry. On the basis of region it has been classified into North America, Latin America Europe Asia Pacific Middle East & Africa (MEA). GABA is a neurotransmitter that is found in the brain and spinal cord. It is an inhibitory neurotransmitter, which means it slows down nerve impulses. GABA has been shown to be effective in treating anxiety, depression, insomnia, and seizures.

Industry Growth Insights published a new data on “GABA (CAS 56-12-2) Market”. The research report is titled “GABA (CAS 56-12-2) Market research by Types (Chemical Synthesis, Biological Fermentation), By Applications (Pharmaceuticals, Food & Beverage, Animal Feeds, Others), By Players/Companies Pharma Foods International, Sekisui Chemical, Zhejiang YiWan Biolabs, Shanghai Richen, Guangdong Luckerkong Biotech, Tianjin Shijitianlong Biotech, Ningxiang Jiayuan Biology Technology, Zhejiang Tianrui Chemical, Taizhou Xinyou Pharmaceutical & Chemical”.

Scope Of The Report

Report Attributes

Report Details

Report Title

GABA (CAS 56-12-2) Market Research Report

By Type

Chemical Synthesis, Biological Fermentation

By Application

Pharmaceuticals, Food & Beverage, Animal Feeds, Others

By Companies

Pharma Foods International, Sekisui Chemical, Zhejiang YiWan Biolabs, Shanghai Richen, Guangdong Luckerkong Biotech, Tianjin Shijitianlong Biotech, Ningxiang Jiayuan Biology Technology, Zhejiang Tianrui Chemical, Taizhou Xinyou Pharmaceutical & Chemical

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

247

Number of Tables & Figures

173

Customization Available

Yes, the report can be customized as per your need.


Global GABA (CAS 56-12-2) Industry Outlook


Global GABA (CAS 56-12-2) Market Report Segments:

The global GABA (CAS 56-12-2) market is segmented on the basis of:

Types

Chemical Synthesis, Biological Fermentation

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Pharmaceuticals, Food & Beverage, Animal Feeds, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Pharma Foods International
  2. Sekisui Chemical
  3. Zhejiang YiWan Biolabs
  4. Shanghai Richen
  5. Guangdong Luckerkong Biotech
  6. Tianjin Shijitianlong Biotech
  7. Ningxiang Jiayuan Biology Technology
  8. Zhejiang Tianrui Chemical
  9. Taizhou Xinyou Pharmaceutical & Chemical

Global GABA (CAS 56-12-2) Market Overview


Highlights of The GABA (CAS 56-12-2) Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Chemical Synthesis
    2. Biological Fermentation
  1. By Application:

    1. Pharmaceuticals
    2. Food & Beverage
    3. Animal Feeds
    4. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the GABA (CAS 56-12-2) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global GABA (CAS 56-12-2) Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


GABA is a neurotransmitter that helps to regulate nerve cells in the brain. It is also involved in controlling muscle activity and blood pressure.

Some of the key players operating in the gaba (cas 56-12-2) market are Pharma Foods International, Sekisui Chemical, Zhejiang YiWan Biolabs, Shanghai Richen, Guangdong Luckerkong Biotech, Tianjin Shijitianlong Biotech, Ningxiang Jiayuan Biology Technology, Zhejiang Tianrui Chemical, Taizhou Xinyou Pharmaceutical & Chemical.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. GABA (CAS 56-12-2) Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. GABA (CAS 56-12-2) Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. GABA (CAS 56-12-2) Market - Supply Chain
   4.5. Global GABA (CAS 56-12-2) Market Forecast
      4.5.1. GABA (CAS 56-12-2) Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. GABA (CAS 56-12-2) Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. GABA (CAS 56-12-2) Market Absolute $ Opportunity

5. Global GABA (CAS 56-12-2) Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. GABA (CAS 56-12-2) Market Size and Volume Forecast by Type
      5.3.1. Chemical Synthesis
      5.3.2. Biological Fermentation
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global GABA (CAS 56-12-2) Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. GABA (CAS 56-12-2) Market Size and Volume Forecast by Application
      6.3.1. Pharmaceuticals
      6.3.2. Food & Beverage
      6.3.3. Animal Feeds
      6.3.4. Others
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global GABA (CAS 56-12-2) Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. GABA (CAS 56-12-2) Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global GABA (CAS 56-12-2) Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. GABA (CAS 56-12-2) Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global GABA (CAS 56-12-2) Demand Share Forecast, 2019-2026

9. North America GABA (CAS 56-12-2) Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America GABA (CAS 56-12-2) Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America GABA (CAS 56-12-2) Market Size and Volume Forecast by Application
      9.4.1. Pharmaceuticals
      9.4.2. Food & Beverage
      9.4.3. Animal Feeds
      9.4.4. Others
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America GABA (CAS 56-12-2) Market Size and Volume Forecast by Type
      9.7.1. Chemical Synthesis
      9.7.2. Biological Fermentation
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America GABA (CAS 56-12-2) Demand Share Forecast, 2019-2026

10. Latin America GABA (CAS 56-12-2) Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America GABA (CAS 56-12-2) Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America GABA (CAS 56-12-2) Market Size and Volume Forecast by Application
      10.4.1. Pharmaceuticals
      10.4.2. Food & Beverage
      10.4.3. Animal Feeds
      10.4.4. Others
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America GABA (CAS 56-12-2) Market Size and Volume Forecast by Type
      10.7.1. Chemical Synthesis
      10.7.2. Biological Fermentation
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America GABA (CAS 56-12-2) Demand Share Forecast, 2019-2026

11. Europe GABA (CAS 56-12-2) Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe GABA (CAS 56-12-2) Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe GABA (CAS 56-12-2) Market Size and Volume Forecast by Application
      11.4.1. Pharmaceuticals
      11.4.2. Food & Beverage
      11.4.3. Animal Feeds
      11.4.4. Others
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe GABA (CAS 56-12-2) Market Size and Volume Forecast by Type
      11.7.1. Chemical Synthesis
      11.7.2. Biological Fermentation
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Aalysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe GABA (CAS 56-12-2) Demand Share, 2019-2026

12. Asia Pacific GABA (CAS 56-12-2) Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific GABA (CAS 56-12-2) Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific GABA (CAS 56-12-2) Market Size and Volume Forecast by Application
      12.4.1. Pharmaceuticals
      12.4.2. Food & Beverage
      12.4.3. Animal Feeds
      12.4.4. Others
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific GABA (CAS 56-12-2) Market Size and Volume Forecast by Type
      12.7.1. Chemical Synthesis
      12.7.2. Biological Fermentation
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific GABA (CAS 56-12-2) Demand Share, 2019-2026

13. Middle East & Africa GABA (CAS 56-12-2) Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa GABA (CAS 56-12-2) Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa GABA (CAS 56-12-2) Market Size and Volume Forecast by Application
      13.4.1. Pharmaceuticals
      13.4.2. Food & Beverage
      13.4.3. Animal Feeds
      13.4.4. Others
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa GABA (CAS 56-12-2) Market Size and Volume Forecast by Type
      13.7.1. Chemical Synthesis
      13.7.2. Biological Fermentation
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa GABA (CAS 56-12-2) Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global GABA (CAS 56-12-2) Market: Market Share Analysis
   14.2. GABA (CAS 56-12-2) Distributors and Customers
   14.3. GABA (CAS 56-12-2) Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Pharma Foods International
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Sekisui Chemical
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Zhejiang YiWan Biolabs
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Shanghai Richen
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Guangdong Luckerkong Biotech
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Tianjin Shijitianlong Biotech
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Ningxiang Jiayuan Biology Technology
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Zhejiang Tianrui Chemical
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Taizhou Xinyou Pharmaceutical & Chemical
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. COMPANY 10
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us